1. Home
  2. MDGL vs PHI Comparison

MDGL vs PHI Comparison

Compare MDGL & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • PHI
  • Stock Information
  • Founded
  • MDGL 2011
  • PHI 1928
  • Country
  • MDGL United States
  • PHI Philippines
  • Employees
  • MDGL N/A
  • PHI N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • PHI Telecommunications Equipment
  • Sector
  • MDGL Health Care
  • PHI Telecommunications
  • Exchange
  • MDGL Nasdaq
  • PHI Nasdaq
  • Market Cap
  • MDGL 6.1B
  • PHI 5.0B
  • IPO Year
  • MDGL N/A
  • PHI 1953
  • Fundamental
  • Price
  • MDGL $424.95
  • PHI $19.66
  • Analyst Decision
  • MDGL Strong Buy
  • PHI Hold
  • Analyst Count
  • MDGL 10
  • PHI 1
  • Target Price
  • MDGL $474.67
  • PHI N/A
  • AVG Volume (30 Days)
  • MDGL 383.6K
  • PHI 132.0K
  • Earning Date
  • MDGL 10-30-2025
  • PHI 11-11-2025
  • Dividend Yield
  • MDGL N/A
  • PHI 6.19%
  • EPS Growth
  • MDGL N/A
  • PHI 20.57
  • EPS
  • MDGL N/A
  • PHI 2.62
  • Revenue
  • MDGL $515,547,000.00
  • PHI $3,879,170,293.00
  • Revenue This Year
  • MDGL $394.12
  • PHI $3.34
  • Revenue Next Year
  • MDGL $57.74
  • PHI $2.76
  • P/E Ratio
  • MDGL N/A
  • PHI $7.42
  • Revenue Growth
  • MDGL 3421.98
  • PHI 2.02
  • 52 Week Low
  • MDGL $200.63
  • PHI $19.22
  • 52 Week High
  • MDGL $457.16
  • PHI $27.93
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 58.68
  • PHI 35.16
  • Support Level
  • MDGL $425.00
  • PHI $19.43
  • Resistance Level
  • MDGL $440.90
  • PHI $19.71
  • Average True Range (ATR)
  • MDGL 14.17
  • PHI 0.46
  • MACD
  • MDGL -4.03
  • PHI -0.06
  • Stochastic Oscillator
  • MDGL 28.61
  • PHI 12.07

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: